Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. This appears to be a minor version update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-05T19:32:24.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions list and Genetic and Rare Diseases Information Center resources were added. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:40:25.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. No visible changes to the study details were observed.
    Difference
    0.0%
    Check dated 2026-02-04T22:51:06.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and the 'No FEAR Act Data' text. Updated footer labels to 'Last Update Submitted that Met QC Criteria' and introduced 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.3 to v3.3.4; there are no substantive changes to study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:24:23.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section added listing participating sites by state (e.g., Alabama, Arizona, California, District of Columbia, Florida, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Tennessee, Texas, Virginia, Washington). The page revision updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T21:16:56.000Z thumbnail image

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.